CDC42 and glioma: Ma et al disclosed that lncRNA SNHG15 mediates glioma vascular endothelial cells through SNHG15/miR‐153/VEGFA/Cdc42 axis, presenting as therapeutic target for glioma therapy against angiogenesis.